Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2004-11-10
pubmed:abstractText
Clathrin-mediated endocytosis involves the assembly of a network of proteins that select cargo, modify membrane shape and drive invagination, vesicle scission and uncoating. This network is initially assembled around adaptor protein (AP) appendage domains, which are protein interaction hubs. Using crystallography, we show that FxDxF and WVxF peptide motifs from synaptojanin bind to distinct subdomains on alpha-appendages, called 'top' and 'side' sites. Appendages use both these sites to interact with their binding partners in vitro and in vivo. Occupation of both sites simultaneously results in high-affinity reversible interactions with lone appendages (e.g. eps15 and epsin1). Proteins with multiple copies of only one type of motif bind multiple appendages and so will aid adaptor clustering. These clustered alpha(appendage)-hubs have altered properties where they can sample many different binding partners, which in turn can interact with each other and indirectly with clathrin. In the final coated vesicle, most appendage binding partners are absent and thus the functional status of the appendage domain as an interaction hub is temporal and transitory giving directionality to vesicle assembly.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-10380931, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-10966473, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-11257904, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-11389591, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-11514193, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-11687498, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-11756460, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12057195, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12353027, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12504687, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12538641, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12589051, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12621426, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12808037, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12858162, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12858163, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12952941, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-12952949, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-1325974, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-14555962, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-14565955, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-14726597, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-14981508, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-3417785, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-6149117, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-7637788, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-8910509, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-9651678, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-9694653, http://linkedlifedata.com/resource/pubmed/commentcorrection/15496985-9920862
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0261-4189
pubmed:author
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4371-83
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:15496985-Adaptor Protein Complex 2, pubmed-meshheading:15496985-Amino Acid Motifs, pubmed-meshheading:15496985-Animals, pubmed-meshheading:15496985-Binding Sites, pubmed-meshheading:15496985-COS Cells, pubmed-meshheading:15496985-Cercopithecus aethiops, pubmed-meshheading:15496985-Clathrin, pubmed-meshheading:15496985-Clathrin-Coated Vesicles, pubmed-meshheading:15496985-Crystallography, X-Ray, pubmed-meshheading:15496985-Endocytosis, pubmed-meshheading:15496985-Enzyme Inhibitors, pubmed-meshheading:15496985-Ligands, pubmed-meshheading:15496985-Mass Spectrometry, pubmed-meshheading:15496985-Models, Biological, pubmed-meshheading:15496985-Models, Molecular, pubmed-meshheading:15496985-Mutagenesis, Site-Directed, pubmed-meshheading:15496985-Nerve Tissue Proteins, pubmed-meshheading:15496985-Phosphoric Monoester Hydrolases, pubmed-meshheading:15496985-Protein Binding, pubmed-meshheading:15496985-Protein Structure, Tertiary, pubmed-meshheading:15496985-Proteomics, pubmed-meshheading:15496985-Rats, pubmed-meshheading:15496985-Water
pubmed:year
2004
pubmed:articleTitle
Evolving nature of the AP2 alpha-appendage hub during clathrin-coated vesicle endocytosis.
pubmed:affiliation
Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
pubmed:publicationType
Journal Article
More...